Gingival Enlargement in Children Treated With Antiepileptics

Abstract

This study was conducted to determine the occurrence, severity, and risk factors of gingival enlargement in children treated with valproate and other nonvalproate antiepileptic drugs. A cross-sectional study was carried out in which data obtained from 68 epileptic children under treatment were compared with those from 50 controls. A structured questionnaire was used to collect data on patients' demographics, dental and oral hygiene practices, and medication history. Gingival enlargement, gingival index, plaque index, and probing depth were measured to assess periodontal health. The chi-square and Fisher exact tests were used in statistical analysis. In case of significance, a detailed chi-square analysis was carried out to determine the origin of the difference. Patients in both the valproate and nonvalproate groups showed significantly higher gingival enlargement, gingival index, plaque scores, and pocketing (P < .001 and P < .01, respectively) than the control group. In the valproate group, the duration of the treatment had a significant effect on gingival enlargement (P < .001) but not on gingival index, plaque index, and probing depth values (P > .05). Toothbrushing was most frequent in the control group ( P = .000) and more frequent in the valproate group than the nonvalproate group (P = .024). Our study showed significant differences regarding gingival enlargement in children treated with valproate. These findings illustrate that epileptic children on valproate are at risk of periodontal problems. (J Child Neurol 2004; 19:958-963).

Get full access to this article

View all access options for this article.

References

Majola MP , McFadyen ML , Connolly C. , et al: Factors influencing phenytoin-induced gingival enlargement. J Clin Periodontol 2000;27:506—512.

Thomason JM , Seymour RA , Rawlins MD : Incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients in general medical practice. Community Dent Oral Epidemiol 1992;20:288—291.

Ogunbodede EO , Adamolekun B. , Akintomide AO : Oral health and dental treatment needs in Nigerian patients with epilepsy. Epilepsia 1998;39:590—594.

Perlík F. , Kolínová M. , Zvárová J. , et al: Phenytoin as a risk factor in gingival hyperplasia. Ther Drug Monit 1995;17:445—448.

Delasnerie-Lauprêtre N. , Turpin JC : Evaluation of the prevalence of side effects of phenobarbital in the Champagne-Ardenne reion (France). Pathol Biol 1991;39:780—784.

Katz J. , Givol N. , Chaushu G. , et al: Vigabatrin-induced gingival overgrowth. J Clin Periodontol 1997;24:180—182.

Wondimu B. , Sandberg J. , Modéer T. : Gingival overgrowth in renal transplant patients administered cyclosporin A in mixture or in capsule form. A longitudinal study. Clin Transplant 1996;10:71—76.

Somacarrera ML , Hernández G. , Acero J. , et al: Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994;65:671—675.

Steele RM , Schuna AA , Schreiber RT : Calcium antagonist-induced gingival hyperplasia. Ann Intern Med 1994;120:663—664.

10.

Miller CS , Damm DD : Incidence of verapamil-induced gingival hyperplasia in a dental population . J Periodontol 1992;63:453—456.

11.

Bowman J. , Levy B. , Grubb R. : Gingival overgrowth induced by diltiazem. Oral Surg Oral Med Oral Pathol 1988:65:183—185.

12.

Fattore L. , Stablein M. , Bredfeldt G. , et al: Gingival hyperplasia. A side effectofnifedipineand diltiazem. Spec Care Dent 1991;11:107—109.

13.

Seymour RA : Calcium channel blockers and gingival overgrowth. Br Dent J 1991;170:376—379.

14.

Bullón P. , Machuca G. , Martinez-Sahuquillo A. , et al: Clinical assessment of gingival hyperplasia in patients treated with nifedipine. J Clin Peridontol 1994;21:256—259.

15.

Kimball OP : The treatment of epilepsy with sodium diphenylhydantoinate. JAMA 1939;112:1244—1245.

16.

Lundström A. , Eeg-Olofsson O. , Hamp SE : Effects of antiepileptic drug treatment with carbamazepine or phenytoin on the oral state of children and adolescents. J Clin Periodontol 1982;9: 482—488.

17.

Seymour RA , Smith DG , Turnbull DN : The effects of phenytoin and sodium valproate on the periodontal health of adult epileptic patients. J Clin Periodontol 1985;12:413—419.

18.

Dahllöf G. , Axio E. , Modéer T. : Regression of phenytoin-induced gingival overgrowth after withdrawal of medication . Swed Dent J 1991;15:139—143.

19.

Syrjanen S. , Syrjanen K. : Hyperplastic gingivitis in a child receiving sodium valproate treatment. Proc Finn Dent Soc 1979;75:95—98.

20.

Russo LS : Valproate-induced stomatitis. Neurology 1981 ;31: 329—331.

21.

Eeg-Olofsson O. , Lundstrom A. , Hamp SE : Oral state of children with epilepsy on treatment with sodium valproate. Scand J Dent Res 1983 ;91:219—223.

22.

Löe H. , Silness J. : Periodontal diseases in pregnancy. Acta Odontol Scand 1963;21:533—551.

23.

Löe H. : The gingival index, the plaque index and the retention index systems . J Periodontol 1967;38(Suppl):610.

24.

Silness J. , Löe H. : Periodontal diseases in pregnancy. Acta Odontol Scand 1964;22:121—135.

25.

Listgarten MA : Periodontal probing: What does it mean? J Clin Periodontol 1980; 7:165-176.

26.

Angelopoulos AP , Goaz PW : Incidence of diphenylhydantoin hyperplasia . Oral Surg Oral Med Oral Pathol 1972;34:898—906.

27.

Miranda J. , Brunet L. , Roset P. , et al: Prevalence and risk of gingival enlargement in patients treated with nifedipine. J Periodontol 2001;72:605—611.

28.

Brodie MJ , Dichter MA : Antiepileptic drugs. N Engl J Med 1996;334:168—175.

29.

Ohtsuka Y. , Amano R. , Mizukawa M. , et al: Treatment of intractable childhoodepilepsywithhigh-dosevalproate . Epilepsia 1992;33:158—164.

30.

Dreiffus FE , Langer DH : Side effects of valproate. Am J Med 1988;(Suppl A):34—41.

31.

Kamali F. , McLaughlin WS , Ball DE , et al: The effect of multiple anticonvulsant therapy on the expression of phenytoin-induced gingival overgrowth. J Clin Periodontol 1999;26:802—805.

32.

Brunet L. , Miranda J. , Roset P. , et al: Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs. Eur J Clin Invest 2001;31:781—788.

33.

Brown RS , Beaver WT , Bottomley WK : On the mechanisms of drug induced gingival hyperplasia. J Oral Pathol Med 1991;20:201—209.

34.

Hassell TM , Gilbert GH : Phenytoin sensitivity of fibroblasts as the basis for susceptibility to gingival enlargement. Am J Pathol 1983;112:218—223.

35.

Modeer T. , Domeij H. , Anduren I. , et al: Effect of phenytoin on the production of interleukin-6 and interleukin-8 in human gingival fibroblasts. J Oral Pathol Med 2000;29:491—499.

36.

Hong HH , Trackman PC : Cytokine regulation of gingival fibroblast lysyl oxidase, collagen, and elastin . J Periodontol 2002; 73:145—152.

37.

Sasaki T. , Maita E. : Increased bFGF level in the serum of patients with phenytoin-induced gingival overgrowth. J Clin Periodontol 1998 ;25:42—47.